Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder

NCT: NCT04649892 · RECRUITING

NCT IDNCT04649892
StatusRECRUITING
Start Date2026-07-01
Completion2027-07
SponsorUniversity of Sao Paulo (OTHER)
First posted
Last updated

Brief Summary

It is a double blind controlled study to test the hypothesis that it's possible to predict the response to naltrexone in Videogame Disorder with the use of Eye Tracking device, during a period of 12 weeks

Frequently Asked Questions

What is Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder?

Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder is a clinical trial registered under NCT04649892. Current status: RECRUITING.

What is the status of NCT04649892?

The current status of NCT04649892 (Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder) is: RECRUITING.

When did Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder start?

Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.